Investor Lilly Endowment Inc
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Lilly Endowment Inc . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2025-04-16 13G/A LLY / Eli Lilly and Company 96,891,978 96,016,978
2025-01-27 13G/A LLY / Eli Lilly and Company 99,768,810 96,891,978
2024-10-23 13G/A LLY / Eli Lilly and Company - Depositary Receipt (Common Stock) 96,891,978
2024-01-26 13G/A LLY / Eli Lilly and Company 102,948,810 99,768,810
2023-01-25 13G/A LLY / Eli Lilly and Company 107,463,810 102,948,810
2022-01-27 13G/A LLY / Eli Lilly and Company 111,132,343 107,463,810
2021-01-21 13G/A LLY / Eli Lilly and Company 144,560,599 111,132,343
2020-01-14 13G/A LLY / Eli Lilly and Company 118,015,304 144,560,599
2020-01-13 13G/A ARMP / Armata Pharmaceuticals, Inc. 114,560,599
2019-01-14 13G/A LLY / Eli Lilly and Company 123,075,804 118,015,304
2018-01-17 13G/A LLY / Eli Lilly and Company 125,575,804 123,075,804
2017-01-13 13G/A LLY / Eli Lilly and Company 127,860,804 125,575,804
2016-01-12 13G/A LLY / Eli Lilly and Company 127,860,804
2015-01-21 13G/A LLY / Eli Lilly and Company 131,405,804